$COAG
Hemab Therapeutics Holdings, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$30.80
▲+7.32%+$2.10
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateHemab Therapeutics Holdings, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is COAG up today? It is at $30.80 (+7.32%), and our scanner flagged it 77 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment COAG spikes, and full due diligence on COAG — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $COAG 77 times in the last 30 days. Create a free account to track $COAG, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on COAG from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on COAG from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
COAG last traded at $30.80, up 7.32% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is next expected to report earnings on Tuesday, November 10, 2026, about 32 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The COAG Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged COAG 77 times in the last 30 days.
COAG (Hemab Therapeutics Holdings, Inc. Common Stock) trades on XNAS, with a market cap of about $1.44B in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge COAG for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$COAG discussion
Sign in to ask a question or join the discussion.